Resveratrol suppresses doxorubicin-induced cardiotoxicity by disrupting E2F1 mediated autophagy inhibition and apoptosis promotion

Jun Gu(Soochow University), Changqian Wang(Shanghai Ninth People's Hospital), Jianan Pan(Shanghai Jiao Tong University), Junfeng Zhang(Shanghai Jiao Tong University), Huili Zhang(Tongji University), Jianying Yu(Shanghai Ninth People's Hospital)
Biochemical Pharmacology
February 21, 2018
Cited by 92


Related Papers